coronavirus within the next four months, the head of German pharmaceutical company BioNTech, which developed the first widely approved COVID-19 vaccine with U.S.
partner Pfizer, said Wednesday.While the exact threshold required to reach that critical level of immunization remains a matter of debate, experts say a level above 70 per cent would significantly disrupt transmission of the coronavirus within a population.“Europe will reach herd immunity in July, latest by August,” Ugur Sahin, BioNTech’s chief executive, told reporters.His company’s vaccine makes up a large share of the doses administered in Europe and North America, where it is more commonly known as the Pfizer shot.Sahin said data from people who have received the vaccine show.